Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology

Area of Science:

• Endocrinology
• Metabolic Research
• Cell Biology

Background:

• Amylin is a 37 amino-acid peptide produced by islet beta-cells and cosecreted with insulin.
• Amylin aggregation contributes to amyloid formation and beta-cell degeneration.
• Amylin plays a role in regulating fuel metabolism, with effects on muscle and potentially the liver.

Purpose of the Study:

• To investigate the physiological and pathological roles of amylin.
• To understand amylin's contribution to amyloid formation and beta-cell function.
• To elucidate amylin's actions in fuel metabolism and its potential link to insulin resistance.

Main Methods:

• Analysis of amylin production and secretion from islet beta-cells.
• Investigation of amylin aggregation and amyloid formation.
• Studies on amylin's effects on glucose and lactate metabolism in muscle and liver.
• Comparison of amylin actions with calcitonin gene-related peptides (CGRP).

Main Results:

• Amylin aggregation is implicated in amyloid formation and beta-cell degeneration.
• Amylin opposes glycogen synthesis and promotes glycogenolysis and glycolysis in muscle, increasing plasma lactate.
• Amylin may indirectly decrease insulin-induced glucose uptake, contributing to insulin resistance.
• Amylin exhibits actions similar to CGRP, potentially affecting fuel metabolism and insulin secretion.

Conclusions:

• Amylin's aggregation and its role in amyloid formation are significant factors in beta-cell health.
• Amylin actively regulates fuel metabolism, influencing lactate production and potentially contributing to insulin resistance.
• Further research is needed to fully understand the physiopathological consequences of amylin deficiency or excess.